Altimmune (ALT) Capital Expenditures (2010 - 2026)
Altimmune (ALT) posted quarterly Capital Expenditures of $21000.0 for Q1 2026, up 2000.0% quarter-over-quarter from $1000.0 in Q4 2025.
Powered by 
Analysis
Altimmune (ALT) Capital Expenditures (2010 - 2026) Analysis & Trends
Altimmune (ALT) has reported Capital Expenditures for 15 consecutive years, with $21000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures changed N/A year-over-year to $21000.0; the TTM figure through Mar 2026 stood at $22000.0 (changed N/A YoY), while the FY2025 annual figure was $11000.0, changed N/A from the prior year.
- Capital Expenditures climbed to $21000.0 in Q1 2026 per ALT's latest filing, from $1000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $60000.0 in Q3 2022 and bottomed at -$4000.0 in Q2 2023.
- Historically, Capital Expenditures has averaged $24375.0 across 4 years, with a median of $20000.0 in 2022.
- On a YoY basis, Capital Expenditures climbed as much as 466.67% in 2023 and fell as far as 121.05% in 2023.
- Altimmune's Capital Expenditures stood at $38000.0 in 2022, then plunged by 110.53% to -$4000.0 in 2023, then soared by 125.0% to $1000.0 in 2025, then surged by 2000.0% to $21000.0 in 2026.
- Business Quant data shows ALT's Capital Expenditures at $21000.0 in Q1 2026, $1000.0 in Q4 2025, and -$4000.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Altimmune | 636.07 Mn | 636.07 Mn | - | 32,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2023 | -4,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 38,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 147,000.00 |
| Sep 30, 2021 | 70,000.00 |
| Jun 30, 2021 | 7.69 Mn |
| Mar 31, 2021 | 4.21 Mn |
| Dec 31, 2020 | 103,628.00 |
| Sep 30, 2020 | 59,728.00 |
| Jun 30, 2020 | 22,470.00 |
| Mar 31, 2020 | 18,131.00 |
| Sep 30, 2019 | 1.00 |
| Mar 31, 2019 | 1,226.00 |
| Dec 31, 2018 | 7,053.00 |